Federal Supply Schedule 36F79722D0213
Award Date
9/15/22
Last Date to Order
9/14/27
Federal Agency
Veterans Integrated Service Network 12
Awardee
Supernus Pharmaceuticals, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Nextgen Pharmaceuticals LLC. The contract provides for drugs, pharmaceuticals, and hematology related products under Schedule 65 IB. With a potential value of $400,000 and a period of performance through July 2028, the multiple award contract aims to meet the healthcare needs of veterans through the procurement of pharmaceuticals and...
The Federal Supply Schedule contract is awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued up to $1,155,030.00, has an ultimate completion date of August 31, 2029 and was awarded to Soleva Pharma LLC, a for-profit limited liability company, on September 1, 2024. The contract is for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS for VISN 12. As a Federal Supply Schedule...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Neurelis Inc. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, which covers a broad range of pharmaceutical and related products. The contract has a ceiling value of $7,410,000.00 and a period of performance extending to August 14, 2026. As a Federal Supply Schedule contract, this is a multiple award vehicle that allows federal agencies to procure the contracted products...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Urovant Sciences Inc., a subsidiary of Sumitovant Biopharma, Inc. This multiple-award contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under FSS-61-IB. The contract has a potential value of $700,000.00 and a period of performance through September 14, 2026. The contract aims to provide the Department...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule contract to Aquestive Therapeutics, Inc., a for-profit organization, manufacturer of goods, and Subchapter S Corporation. The contract is categorized under FSS-61-IB, Pharmaceuticals and Drugs, with a potential contract value of $225,000.00 and a period of performance from July 1, 2019 to June 30, 2024. The contract seeks to procure drugs, pharmaceuticals,...
The Federal Supply Schedule contract is a multiple award IDV under the Pharmaceuticals and Drugs schedule awarded by the Department of Veterans Affairs Veterans Health Administration. The contract aims to provide drugs, pharmaceuticals, and hematology-related products to VHA facilities. The prime contractor is Nabriva Therapeutics US Inc., a for-profit organization. The contract has a potential value of $225,000 and a period of performance through October 15, 2023. No set-asides were used in the...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12, a civilian agency of the U.S. federal government, to Saptalis Pharmaceuticals, LLC, a self-certified small disadvantaged business. The $565,000.00 contract has a period of performance ending on March 14, 2030 and provides for the delivery of drugs, pharmaceuticals, and hematology-related products under the 65 I B Federal Supply Schedule. The contract was competitively awarded without the use of any...
This Federal Supply Schedule (FSS) contract was awarded by the U.S. Department of Veterans Affairs (VA) to Apnar Pharma, LP, a minority-owned, small disadvantaged business. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and enables the VA to procure a wide range of pharmaceutical and hematology-related products from the vendor. The $2,225,000 multiple-award contract has a period of performance through June 14, 2026. As a Federal Supply Schedule contract, it...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs, Veterans Integrated Service Network 12, to Aquestive Therapeutics, Inc., a for-profit manufacturer of goods and subchapter S corporation. The contract, which has a maximum value of $25,000.00 and a period of performance through March 31, 2025, provides for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B of the Federal Supply Schedule. The contract is a multiple...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Federal Supply Schedule (FSS) contract to Vistapharm, Inc., a for-profit manufacturer of pharmaceutical goods. The contract, with a potential value of $20,359,397, is under the VA's Veterans Integrated Service Network 12 and is part of the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract has a period of performance from September 30, 2017, to March 31, 2024, and does not utilize any...